Noah Labs selected for EIC support to advance voice-based heart monitoring

Noah Labs has been selected for the European Innovation Council’s Accelerator programme. The support includes a €2.5 million grant and up to €8.5 million in potential equity investment, creating a possible financing package of up to €11 million.

The company is developing voice analysis as a way to help identify changes in patients with heart failure. The funding will support further research and clinical validation of this approach, alongside development of its wider cardiovascular care platform.

Noah Labs also offers Ark, its MDR-certified platform for remote monitoring using data from medical devices. The voice technology is a separate development effort undergoing clinical validation.

We’re pleased to see the team receive this support as it works to bring new tools into cardiovascular care.